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INTRODUCTION:  Thyroglosal  duct  cyst  is a common  anomaly  with  an  incidence  of 7% in  adults,  the  rate
of carcinoma  in TGDC  is 0.7–1.6%,  and  are  extremely  rare  those  originated  in the  hyoid  bone.
PRESENTATION  OF  CASE:  A 60  years  old male  patient,  had  a hard mass  in  the  anterior  neck.  CT revealed  a
hyoid  tumor.  Hyoid  bone  resection  was  performed,  the  pathological  report  show  a conventional  papillary
carcinoma  in  bone  tissue.  We  rule out primary  tumor  in  thyroid  gland.  Five  years  later,  he  developed  a neck
node  recurrence.  Total  thyroidectomy  and  a selective  left  neck  dissection  (II–IV  levels) was  performed.
He  received  radioiodine  adjuvant  treatment.
DISCUSSION:  Hyoid  cancer  originates  of  a persistent  thyroglosal  duct  remnants  inside  hyoid  bone.yoid cancer
apillary hyoid cancer
CONCLUSION:  We  propose  to add  a  new  subdivision  to  pathology  derived  from  thyroglosal  duct  remnants).
The diagnostic  approach  with  ultrasound  and  CT are  necessary.  A primary  in  te  hyoid gland  mustang  be
discorded,  and  then  the entire  hyoid  bone  must  be  removed.  Treatment  of  the thyroid  gland  and  neck
should  be  considered  when  there  are  signiﬁcant  risk factors  of  recurrence,  similarly  to  thyroid  cancer
based  on  the risk assessment.
©  2016  The  Author(s).  Published  by  Elsevier  Ltd  on behalf  of IJS  Publishing  Group  Ltd.  This  is  an  open
access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).. Introduction
The thyroid starts to develop at the 3–5 week embryo stage
n the area that later becomes the foramen cecum, it descends in
he midline through the muscle of the tongue, and then anterior
o the hyoid bone and larynx (30% the tract mat  be found poste-
ior to hyoid), to override the fourth pharyngeal arch artery, and
eaches its paratracheal position at the 7 week embryo stage, leav-
ng the thyroglossal duct to obliterate and disappear by the 9–10.
f obliteration and disappearance fail to occur, the remnants of the
hyroglossal duct (TGD) are prone to become a thyroglossal duct
yst (TGDC) [1–6]. The TGDC had an incidence of 7% in adults, rep-
esents 70% of all congenital neck anomalies, and more than 50%
ontain ectopic functional thyroid tissue. It is more frequent in the
rst two decades of life [1,4,15]. The rate of carcinoma in TGDC is
.7–1.6% [14], and most of times is a well differentiated papillary
arcinoma, as thyroid carcinoma (PTC) less common is a follicular
arcinoma [6].
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reativecommons.org/licenses/by-nc-nd/4.0/).The clinical presentation is a mass in the midline of the neck at
hyoid bone. The epithelial lining of a TGDC ranges from squamous
epithelium to pseudostratiﬁed ciliated columnar epithelium. Sali-
vary gland tissue or thyroid gland tissue may be seen in the wall of
the cyst [4,6].
Imaging studies displays a tumor at the level of hyoid bone.
In Sonography it appears as well-deﬁned cystic masses, with thin
walls and late enhancement [7]. The FNA in TGDC had moderately
sensitive [8]. The CT is very sensitive to evaluate bone, it is used to
evaluate site of the mass, relationship with adjacent structures and
characteristics, as thickness of walls, margins, internal septa, rim
enhancement, internal density, and the presence or absence of the
thyroid gland [9]
Surgical extirpation of TGDCs is recommended, because of the
likelihood of recurrent infections and the rare possibility of malig-
nancy [4]. The Sistrunk procedure has been a standard surgical
procedure for the TGDC, the main aim is the complete removal of
the cyst and the duct [2,4,10]. The recurrence rate is less 5–30%.
The Sistrunk operation is adequate for most patients with inci-
dentally diagnosed TGDC carcinoma in the presence of a clinically
and radiologically normal thyroid gland [4,13]. There are no reports
on the surgical technique for hyoid.Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. CT scan. Large solid mass at the level of hyoid bone.
roid cartilage extension.
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. Clinical case
60 years—old masculine patient, with history of smoking, pre-
ented an anterior midline neck mass that grew slowly and
rogressively over two years, associated with excessive salivation
nd hoarseness; Physical examination revealed a hard mass located
n the anterior neck.
Thyroid functional tests, serum thyroxine (T4), free triiodothy-
onine (T3) and thyroid stimulating hormone (TSH), were within
ormal limits. A computed tomography scan (CT) revealed a large
olid, heterogeneous mass, at the level of the hyoid bone of
5 × 35 × 39 mm in size, which extended to the thyroid cartilage
Figs. 1 and 2).
We  decided a surgical treatment. A hyoid bone resection was
erformed, ﬁnding a hyoid bone tumor of 7 × 4 cm.  The pathological
eport revealed a suspected 4 × 2 × 1.1 cm conventional papillary
arcinoma with metastasis to the bone tissue and soft tissue exten-
ion (Figs. 3–5). US failed to show a primary in thyroid gland and
odal metastases. After multidisciplinary discussion, we  suspected
 primary papillary carcinoma of the thyroglosal duct remnant into
e hyoid and decided to keep the patient under surveillance.
Five years later, physical examination revealed cervical lymph
odes; Neck ultrasound reported a suspected malignancy cervical
ymph node (Fig. 6) and the ﬁne needle aspiration (FNA) revealed
 papillary carcinoma.
The patient underwent total thyroidectomy and left neck dis-
ection of levels II − IV. The pathological evaluation revealed theFig. 3. Pathological report. Hyoid bone resection.
thyroid gland with multinodular goiter without any neoplastic foci
into thyroid gland and a metastatic papillary thyroid carcinoma was
identiﬁed in 9 out of 17 lymph nodes (Figs. 7–9).
Postoperative radioactive iodine treatment and thyroid hor-
mone suppression were recommended. At the present day, the
patient was followed up with physical examination, thyroid func-
tional tests and neck ultrasonography. The tumor had not recurred
one year after the operation.
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Fig. 4. Pathological report. Hematoxylin and eosin staining, was observed a malignancy forming papillae and follicles.
Fig. 5. Pathological report. Papillary carcinoma with bone inﬁltration and vascular permeation.
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. Discussion
The rate of carcinoma in TGDC is 0.7–1.6% [14], of these,
ell differentiated papillary thyroid carcinomas (PTC) represents
6.7–95%, followed by follicular 16.7%, tall cell variant 11.1% and
lassic PTC with focal tall cell 5.6%; medullary carcinoma has not
een reported in literature [6,14].
Of patients taken to thyroidectomy, 50% had incidental PTC with
 size of 0.1–0.3 cm [6,14]. There is a pathological report of the
hyroglossal duct penetrated the hyoid bone, result of a forward
rowth of the hyoid bone after ﬁrst pushing the TGD outward, the
hape of the bone adapts to the TGD and eventually completely
ngulfs it [2], this supports the diagnosis of hyoid cancer of this
ase report.
The locations of TGDC are classiﬁed into 4 subdivisions: (1)
ntralingual, (2) suprahyoid or submental, (3) thyrohyoid, and (4)
uprasternal. We  propose add a new subdivision “Hyoid”.
The clinical presentation it’s similar to a TGDC, with a mass in the
idline of the neck at hyoid bone. The rest of TGDC are located just
bove or below the hyoid bone, but approximately one-third maytral/peripheral) blood vessels, located in left cervical levels IIA, IIB, III and IV.
present submentally or in lower cervical levels [4]. Less than 1% are
located off the midline [1,4]. The epithelial lining of a TGDC ranges
from squamous epithelium to pseudostratiﬁed ciliated columnar
epithelium. Salivary gland tissue or thyroid gland tissue (22–46%)
may  be seen in the wall of the cyst [4,6].
Imaging studies revealed a tumor at the level of hyoid bone.
Sonographic appearances in adults were identiﬁed: anechoic (28%),
homogeneously hypoechoic with internal debris (18%), pseu-
dosolid (28%), and heterogeneous (28%) [7]. The FNA in TGDC is
moderately sensitive for a preoperative evaluation, with PPV of 69%
[8]. But we believe that the main use of ultrasound is to assess the
thyroid gland and cervical lymph node levels and guide a FNA. The
CT is very sensitive to evaluate bone, It used to evaluate site of the
mass, relationship to the midline, walls, margins, internal septa,
rim enhancement, internal density, and the presence or absence of
the thyroid gland [9]. We  suggest that a patient with hyoid tumor
must be evaluated with ultrasound and CT of the neck.
The Sistrunk procedure has been a standard surgical procedure
for benign thyroglossal cyst, involves bloc cystectomy and cen-
tral hyoidectomy, with tract excision up to the foramen cecum,
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Fig. 7. Pathological evaluation. Total thyroidectomy and left neck dissection of lev-
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The hyoid cancer originates of a persistent TGC result of a for-ls II–IV. Thyroid gland without macroscopic tumor.
he main aim is the complete removal of the cyst and the duct
2,4,10,14]. The recurrence rate is less 10%, but are reports ranging
–30%. The recurrence rate has been associate with an incorrect
nitial diagnosis in 50% of cases, previous infection in 15% of cases,
nusual locations in 15% of cases, and lack of removal of tongue
ase muscle tissue and relative inexperience of the surgeon, both
n 2% of cases [11,14].
The main complication of surgery for TGDC is infection (10–70%)
4]. Others complications are hematoma, blood transfusion, viola-
ion of the airway or tracheotomy, (hypoglossal) nerve paralysis,
ypothyroidism, and death [12]. The posterior hyoid space is
emarcated caudally by the inferior rim of the hyoid, cranially by
he superior rim of the hyoid and thyrohyoid membrane, ventrally
y the posterior surface of the hyoid, and dorsally by the thyrohyoid
embrane facilitates complete resection and can prevent inade-
Fig. 8. Pathological evaluation. Total thyroidectomy and left neck dis
Fig. 9. Pathological evaluation. Total thyroidectomy and left neck dissectionPEN  ACCESS
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quate cyst resection in the area of the hyoid, reporting a recurrence
rate of less than 2% [4].
The surgical management of TGDC carcinoma is based on the
risk assessment, similar to well differentiated thyroid cancer, based
on the revised 2015 American Thyroid Association (ATA) guide-
lines [15,16]. The Sistrunk operation is adequate for most patients
with low risk with incidentally diagnosed TGDC (No local or distant
metastases, all macroscopic tumor resected, not aggressive his-
tology, no vascular invasion, without cervical metastasis, younger
than 45 years, no radiation history and tumor less than 4 cm), the
addition of total thyroidectomy did not have an impact on out-
come, with a 95% cure rate [4,13,15]. In a patients with high risk
are destined to an additional total thyroidectomy and postopera-
tive radiactive iodine ablation therapy, the loco-regional control is
a top priority [14,15].
There are no reports on the surgical technique for hyoid cancer
but we consider should evaluate the absence of TGDC, and then
remove the entire hyoid bone, the treatment of the thyroid gland
and neck should be handled in the same way  that a thyroid cancer;
based on the risk assessment. In this case after a careful study, not
primary tumor was demonstrated in the thyroid gland and cervical
lymph nodes. The patient recurred in neck and the thyroidectomy
was perform because at this time he had indications of radiative
iodine ablation therapy.
This is the ﬁrst report of a papillary carcinoma of hyoid, we offer a
review of the embryological mechanisms leading to this pathology,
as well as the diagnostic tools. We  propose a new classiﬁcation of
thyroglosal duct remnants and appropriate surgical treatment for
this patients.
4. Conclusionsward growth of the hyoid bone after ﬁrst pushing the TGD outward,
the shape of the bone adapts to the TGD and eventually completely
section of levels II–IV. Thyroid gland with multinodular goiter.
 of levels II–IV. Lymph nodes with metastasis of papillary carcinoma.
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ngulfs it. We  propose to add a new subdivision to the localization
f TGDC (Hyoid). Histology and its frequency is similiar to the thy-
oid cancer. The diagnostic approach with ultrasound to assess the
hyroid gland and cervical lymph node levels and lead a FNA and
T for evaluate bone. We  consider should evaluate the absence of
GDC, and then remove the entire hyoid bone, the treatment of the
hyroid gland and neck should be handled in the same way that a
hyroid cancer; based on the risk assessment.
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